Glutathione and pH serial responsive functional mesoporous silica nanoparticles for drug delivery

被引:1
作者
He, Liang [1 ,2 ]
Nan, Xueyan [1 ]
Wang, Tong [1 ]
Bai, Pengli [1 ,3 ,4 ]
机构
[1] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou 215163, Peoples R China
[2] Qingdao Univ, Coll Chem & Chem Engn, Inst Biomed Mat & Engn, Qingdao 266071, Peoples R China
[3] Univ Sci & Technol China, Hefei 230026, Peoples R China
[4] Tianjin Guokeyigong Sci & Technol Dev Co Ltd, Tianjin 300399, Peoples R China
关键词
CHITOSAN NANOPARTICLES; GRAPHENE OXIDE; CARBON DOTS; CO-DELIVERY; CANCER; NANOCARRIERS; DOXORUBICIN; THERAPY;
D O I
10.1049/mnl.2019.0317
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
In this work, a novel glutathione and pH serial dual-responsive drug delivery system has been developed, which was constructed with chitosan (CS), carbon dots (CDs) and hyaluronic acid (HA) modified the mesoporous silica nanoparticles (MSNs). The system showed excellent drug loading efficiency, controlled release and targeted delivery. In addition, the platform (MSN-CS@HA-CDs) exhibited fluorescence imaging property. The prepared drug delivery system appeared to be a promising cancer treatment platform.
引用
收藏
页码:291 / 295
页数:5
相关论文
共 50 条
  • [21] Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery
    Moghaddam, Seyyed Pouya Hadipour
    Yazdimamaghani, Mostafa
    Ghandehari, Hamidreza
    JOURNAL OF CONTROLLED RELEASE, 2018, 282 : 62 - 75
  • [22] Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery
    Baeza, Alejandro
    Colilla, Montserrat
    Vallet-Regi, Maria
    EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (02) : 319 - 337
  • [23] Aldehyde-functionalized dendritic mesoporous silica nanoparticles as potential nanocarriers for pH-responsive protein drug delivery
    Tian, Zhengfang
    Xu, Yi
    Zhu, Yufang
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2017, 71 : 452 - 459
  • [24] Metal-Phenolic Encapsulated Mesoporous Silica Nanoparticles for pH-Responsive Drug Delivery and Magnetic Resonance Imaging
    Chen, Yan
    Wang, Juan
    Liu, Jianhua
    Lu, Lehui
    ZEITSCHRIFT FUR PHYSIKALISCHE CHEMIE-INTERNATIONAL JOURNAL OF RESEARCH IN PHYSICAL CHEMISTRY & CHEMICAL PHYSICS, 2018, 232 (9-11): : 1733 - 1740
  • [25] A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery
    Zhang, Qing
    Zhao, Haoyu
    Li, Dong
    Liu, Liping
    Du, Shuhu
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2017, 149 : 138 - 145
  • [26] pH-responsive mesoporous silica drug delivery system for targeted cancer chemotherapy
    Bao, Wen
    Ma, Haibo
    Wang, Nan
    He, Zhanhang
    MATERIALS TECHNOLOGY, 2021, 36 (05) : 308 - 316
  • [27] Hyaluronic Acid Oligosaccharide Modified Redox-Responsive Mesoporous Silica Nanoparticles for Targeted Drug Delivery
    Zhao, Qinfu
    Geng, Hongjian
    Wang, Ying
    Gao, Yikun
    Huang, Jiahao
    Wang, Yan
    Zhang, Jinghai
    Wang, Siling
    ACS APPLIED MATERIALS & INTERFACES, 2014, 6 (22) : 20290 - 20299
  • [28] Targeted and stimuli-responsive mesoporous silica nanoparticles for drug delivery and theranostic use
    Aquib, Md
    Farooq, Muhammad A.
    Banerjee, Parikshit
    Akhtar, Fahad
    Filli, Mensura S.
    Boakye-Yiadom, Kofi O.
    Kesse, Samuel
    Raza, Faisal
    Maviah, Mily B. J.
    Mavlyanova, Rukhshona
    Wang, Bo
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2019, 107 (12) : 2643 - 2666
  • [29] Transferrin gated mesoporous silica nanoparticles for redox-responsive and targeted drug delivery
    Chen, Xiaolu
    Sun, Hui
    Hu, Jun
    Han, Xia
    Liu, Honglai
    Hu, Ying
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2017, 152 : 77 - 84
  • [30] Mesoporous silica nanoparticles for drug and gene delivery
    Zhou, Yixian
    Quan, Guilan
    Wu, Qiaoli
    Zhang, Xiaoxu
    Niu, Boyi
    Wu, Biyuan
    Huang, Ying
    Pan, Xin
    Wu, Chuanbin
    ACTA PHARMACEUTICA SINICA B, 2018, 8 (02) : 165 - 177